Ketamine for Complex Regional Pain Syndrome: A Narrative Review Highlighting Dosing Practices and Treatment Response.

[1]  J. Switchenko,et al.  A dose‐escalation clinical trial of intranasal ketamine for uncontrolled cancer‐related pain , 2022, Pharmacotherapy.

[2]  G. Pickering,et al.  Ketamine in chronic pain: A Delphi survey , 2022, European journal of pain.

[3]  Y. Ning,et al.  Plasma inflammatory cytokines and treatment-resistant depression with comorbid pain: improvement by ketamine , 2021, Journal of neuroinflammation.

[4]  F. Huygen,et al.  Ketamine therapy for chronic pain in The Netherlands: a nationwide survey , 2021, Scandinavian journal of pain.

[5]  S. Eldabe,et al.  A prospective long-term follow-up of dorsal root ganglion stimulation for the management of chronic intractable pain. , 2021, Pain.

[6]  S. Bruehl,et al.  The Valencia consensus-based adaptation of the IASP complex regional pain syndrome diagnostic criteria , 2021, Pain.

[7]  K. Ward,et al.  Intranasal Ketamine for Acute Pain , 2021, The Clinical journal of pain.

[8]  A. Dahan,et al.  Ketamine Pharmacokinetics , 2020, Anesthesiology.

[9]  W. Marcantoni,et al.  A systematic review and meta-analysis of the efficacy of intravenous ketamine infusion for treatment resistant depression: January 2009 - January 2019. , 2020, Journal of affective disorders.

[10]  M. Pouraghaei,et al.  Intranasal ketamine versus intravenous morphine for pain management in patients with renal colic: a double-blind, randomized, controlled trial , 2020, World Journal of Urology.

[11]  C. Lambert,et al.  Ketamine and Magnesium for Refractory Neuropathic Pain: A Randomized, Double-blind, Crossover Trial. , 2020, Anesthesiology.

[12]  S. Dursun,et al.  Ketamine as an antidepressant: overview of its mechanisms of action and potential predictive biomarkers , 2020, Therapeutic advances in psychopharmacology.

[13]  R. Schwartzman,et al.  Optimizing the Treatment of CRPS With Ketamine , 2020, The Clinical journal of pain.

[14]  S. Muthukumaraswamy,et al.  Simultaneous EEG/fMRI recorded during ketamine infusion in patients with major depressive disorder , 2019, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[15]  Steven P. Cohen,et al.  Ketamine Infusions for Chronic Pain: A Systematic Review and Meta-analysis of Randomized Controlled Trials. , 2019, Anesthesia and analgesia.

[16]  Nanhua Zhang,et al.  Effect of Intranasal Ketamine vs Fentanyl on Pain Reduction for Extremity Injuries in Children: The PRIME Randomized Clinical Trial , 2019, JAMA pediatrics.

[17]  Cheng-Ta Li,et al.  Rapid inflammation modulation and antidepressant efficacy of a low-dose ketamine infusion in treatment-resistant depression: A randomized, double-blind control study , 2018, Psychiatry Research.

[18]  Ke Xu,et al.  The profile of cognitive impairments in chronic ketamine users , 2018, Psychiatry Research.

[19]  Steven P. Cohen,et al.  Consensus Guidelines on the Use of Intravenous Ketamine Infusions for Chronic Pain From the American Society of Regional Anesthesia and Pain Medicine, the American Academy of Pain Medicine, and the American Society of Anesthesiologists , 2018, Regional Anesthesia & Pain Medicine.

[20]  Vinita Singh,et al.  Intranasal Ketamine and Its Potential Role in Cancer‐Related Pain , 2018, Pharmacotherapy.

[21]  Yajing Wang,et al.  The Effect of Ketamine Infusion in the Treatment of Complex Regional Pain Syndrome: a Systemic Review and Meta-analysis , 2018, Current Pain and Headache Reports.

[22]  L. Hartling,et al.  Intranasal ketamine for procedural sedation and analgesia in children: A systematic review , 2017, PloS one.

[23]  Lucy L Chen,et al.  Intravenous Ketamine Infusions for Neuropathic Pain Management: A Promising Therapy in Need of Optimization , 2017, Anesthesia and analgesia.

[24]  Beth A. Parente,et al.  Prevalence of Specific Types of Pain Diagnoses in a Sample of United States Adults. , 2017, Pain physician.

[25]  P. Staats,et al.  Dorsal root ganglion stimulation yielded higher treatment success rate for complex regional pain syndrome and causalgia at 3 and 12 months: a randomized comparative trial , 2016, Pain.

[26]  T. Deer,et al.  Dorsal root ganglion stimulation approval by the Food and Drug Administration: advice on evolving the process , 2016, Expert review of neurotherapeutics.

[27]  M. Hotopf,et al.  Depression in patients with chronic pain attending a specialised pain treatment centre: prevalence and impact on health care costs , 2016, Pain.

[28]  P. Bourgeois,et al.  Efficacy and safety of oral ketamine for the relief of intractable chronic pain: A retrospective 5‐year study of 51 patients , 2015, European journal of pain.

[29]  A. Machado,et al.  Spinal cord stimulation: a review of the safety literature and proposal for perioperative evaluation and management. , 2015, The spine journal : official journal of the North American Spine Society.

[30]  A. Goebel,et al.  Racemic ketamine 4.5-day infusion treatment of long-standing complex regional pain syndrome—a prospective service evaluation in five patients. , 2015, British journal of anaesthesia.

[31]  R. Kydd,et al.  Relationships Between Psychological Factors, Pain, and Disability in Complex Regional Pain Syndrome and Low Back Pain , 2014, The Clinical journal of pain.

[32]  Jamie Sleigh,et al.  Ketamine – More mechanisms of action than just NMDA blockade , 2014 .

[33]  P. Anderson,et al.  Ketamine: an update on its abuse. , 2014, Journal of pharmacy practice.

[34]  M. Kock,et al.  Ketamine and Peripheral Inflammation , 2013, CNS neuroscience & therapeutics.

[35]  G. Moseley,et al.  Interventions for treating pain and disability in adults with complex regional pain syndrome. , 2013, The Cochrane database of systematic reviews.

[36]  H. Nakanishi,et al.  Microglial Ca2+-Activated K+ Channels Are Possible Molecular Targets for the Analgesic Effects of S-Ketamine on Neuropathic Pain , 2011, The Journal of Neuroscience.

[37]  L. Aarts,et al.  Absence of long‐term analgesic effect from a short‐term S‐ketamine infusion on fibromyalgia pain: A randomized, prospective, double blind, active placebo‐controlled trial , 2011, European journal of pain.

[38]  M. van Kleef,et al.  Distribution of signs and symptoms of Complex Regional Pain Syndrome type I in patients meeting the diagnostic criteria of the International Association for the Study of Pain , 2011, European journal of pain.

[39]  Jingwei Wu,et al.  Reciprocal relationship between pain and depression: a 12-month longitudinal analysis in primary care. , 2011, The journal of pain : official journal of the American Pain Society.

[40]  Wei Wang,et al.  Inhibition of spinal astrocytic c-Jun N-terminal kinase (JNK) activation correlates with the analgesic effects of ketamine in neuropathic pain , 2011, Journal of Neuroinflammation.

[41]  Jürgen Sandkühler,et al.  Long-term potentiation in spinal nociceptive pathways as a novel target for pain therapy , 2011, Molecular pain.

[42]  A. Dahan,et al.  Ketamine for the treatment of chronic non-cancer pain , 2010, Expert opinion on pharmacotherapy.

[43]  R. Schwartzman,et al.  Pharmacodynamic profiles of ketamine (R)- and (S)- with 5-day inpatient infusion for the treatment of complex regional pain syndrome. , 2010, Pain physician.

[44]  P. Bemt,et al.  Use of oral ketamine in chronic pain management: A review , 2010, European journal of pain.

[45]  Erin R. Reichenberger,et al.  Outpatient intravenous ketamine for the treatment of complex regional pain syndrome: A double-blind placebo controlled study , 2009, PAIN®.

[46]  J. Marinus,et al.  Ketamine produces effective and long-term pain relief in patients with Complex Regional Pain Syndrome Type 1 , 2009, PAIN.

[47]  R. Schwartzman,et al.  The Natural History of Complex Regional Pain Syndrome , 2009, The Clinical journal of pain.

[48]  David Borsook,et al.  CNS Measures of Pain Responses Pre- and Post-Anesthetic Ketamine in a Patient with Complex Regional Pain Syndrome. , 2009, Pain medicine.

[49]  R. Schwartzman,et al.  Efficacy of ketamine in anesthetic dosage for the treatment of refractory complex regional pain syndrome: an open-label phase II study. , 2008, Pain medicine.

[50]  P. Crooks,et al.  Effects of norketamine enantiomers in rodent models of persistent pain , 2008, Pharmacology Biochemistry and Behavior.

[51]  M. van Kleef,et al.  Effect of spinal cord stimulation for chronic complex regional pain syndrome Type I: five-year final follow-up of patients in a randomized controlled trial. , 2008, Journal of neurosurgery.

[52]  Erin R. Reichenberger,et al.  Changes in immune and glial markers in the CSF of patients with Complex Regional Pain Syndrome , 2007, Brain, Behavior, and Immunity.

[53]  J. Dieleman,et al.  The incidence of complex regional pain syndrome: A population-based study , 2007, Pain.

[54]  Zhong-qing Chen,et al.  [Effects of subanesthetic dose of ketamine on perioperative serum cytokines in orthotopic liver transplantation]. , 2006, Nan fang yi ke da xue xue bao = Journal of Southern Medical University.

[55]  G. Manzoni,et al.  Epidemiology of typical and atypical craniofacial neuralgias , 2005, Neurological Sciences.

[56]  Edward J Gracely,et al.  Subanesthetic ketamine infusion therapy: a retrospective analysis of a novel therapeutic approach to complex regional pain syndrome. , 2004, Pain medicine.

[57]  D. Carr,et al.  Safety and efficacy of intranasal ketamine for the treatment of breakthrough pain in patients with chronic pain: a randomized, double-blind, placebo-controlled, crossover study , 2004, Pain.

[58]  W. Katon,et al.  Depression and pain comorbidity: a literature review. , 2003, Archives of internal medicine.

[59]  R. McClelland,et al.  Complex regional pain syndrome type I: incidence and prevalence in Olmsted county, a population-based study , 2003, PAIN®.

[60]  T. Iga,et al.  Plasma concentration profiles of ketamine and norketamine after administration of various ketamine preparations to healthy Japanese volunteers , 2003, Biopharmaceutics & drug disposition.

[61]  Marius A Kemler,et al.  Economic evaluation of spinal cord stimulation for chronic reflex sympathetic dystrophy , 2002, Neurology.

[62]  W. Willis.  Long-term potentiation in spinothalamic neurons , 2002, Brain Research Reviews.

[63]  S. Dohi,et al.  Short- and long-term efficacy of oral ketamine in eight chronic-pain patients , 2002, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[64]  Robert Kronenberg.  Ketamine as an Analgesic , 2002 .

[65]  H C de Vet,et al.  Spinal cord stimulation in patients with chronic reflex sympathetic dystrophy. , 2000, The New England journal of medicine.

[66]  D. Talmor,et al.  Ketamine Attenuates the Interleukin-6 Response After Cardiopulmonary Bypass , 1998, Anesthesia and analgesia.

[67]  J. Olney,et al.  Clonidine potentiates the neuropathic pain-relieving action of MK-801 while preventing its neurotoxic and hyperactivity side effects , 1998, Brain Research.

[68]  P. Eide,et al.  Mapping of punctuate hyperalgesia around a surgical incision demonstrates that ketamine is a powerful suppressor of central sensitization to pain following surgery , 1997, Acta anaesthesiologica Scandinavica.

[69]  F. M. Borgbjerg,et al.  Norketamine, the main metabolite of ketamine, is a non-competitive NMDA receptor antagonist in the rat cortex and spinal cord. , 1997, European journal of pharmacology.

[70]  R. Hallin,et al.  Beneficial effects of ketamine in a chronic pain state with allodynia, possibly due to central sensitization , 1995, Pain.

[71]  M. Backonja,et al.  Response of chronic neuropathic pain syndromes to ketamine: a preliminary study , 1994, Pain.

[72]  T. Bliss,et al.  NMDA receptors - their role in long-term potentiation , 1987, Trends in Neurosciences.

[73]  J. Clements,et al.  Bioavailability, pharmacokinetics, and analgesic activity of ketamine in humans. , 1982, Journal of pharmaceutical sciences.

[74]  P. White,et al.  Ketamine--its pharmacology and therapeutic uses. , 1982, Anesthesiology.

[75]  OUP accepted manuscript , 2022, Age And Ageing.

[76]  G. Iolascon,et al.  Complex regional pain syndrome (CRPS) type I: historical perspective and critical issues. , 2015, Clinical cases in mineral and bone metabolism : the official journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases.